Gelonghui, April 25 | Kechuang 100 ETF Huaxia (588800) continued to rise. As of 13:00, Kechuang 100 ETF Huaxia (588800) had an increase of 1.61%, a turnover of 380 million yuan, and a weekly increase of 4.71%. The Science Innovation 100 ETF Huaxia (588800) closely tracks the Shanghai Science and Technology Innovation 100 Index. As the only small to medium capitalization style index on the Science and Technology Innovation Board, Science Innovation 100 gathers the middle market capitalization+liquidity target of the Science and Technology Innovation Board. The industry distribution focuses on next-generation information technology, artificial intelligence, and biotechnology, which is an important gripper for new quality productivity. Guoxin Securities anticipates that the molecular side and denominator side of the Science and Technology Innovation 100 are expected to resonate in 2024, ushering in trending investment opportunities. At the mesoscopic level, the recovery in the growth industry boom cycle is expected to drive the C&E 100 sector upward; at the micro level, high R&D investment+high growth will give Sci-Tech Innovation 100 higher profit elasticity. In the future, in the context of the country's “autonomous and controllable” strategy, it is expected to achieve a “high R&D expenditure → high growth → high profit” operating model. In this round of rebound driven by liquidity, Science Innovation 100 is expected to benefit from higher valuation flexibility. Industry insiders pointed out that the emerging industries mapped by the Science and Technology Innovation Board may become the core force driving economic growth, and are expected to effectively drive China's economic restructuring and industrial transformation and upgrading. At this stage, the Science and Technology Innovation 100 may have fully gained momentum in the trough range and is in a good allocation window. Science Innovation 100ETF Huaxia (588800), OTC connection (Class A: 020291; Class C: 020292)